Pure Global

GenePath Dx JAK2 v2 Real Time qPCR Test Kit - India CDSCO Medical Device Registration

GenePath Dx JAK2 v2 Real Time qPCR Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000138_3382e663fb11e50baaec8b75987d6133_00e3e9f955849a636ccbc45833e0b024. This device is marketed under the brand name Concepta D-DIMER Control. The license holder is BIOSYSTEMS DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
GenePath Dx JAK2 v2 Real Time qPCR Test Kit
UID: MFG/IVD/2020/000138_3382e663fb11e50baaec8b75987d6133_00e3e9f955849a636ccbc45833e0b024

Brand Name

Concepta D-DIMER Control

Device Class

Class C

Approving Authority

Central Drug Standard Control Organisation, South Zone

Product Information

The GenePath Dx JAK2 v2 Real Time qPCR kit is a qualitative kit for detection of JAK2 V617F mutation [JAK2:c.G1849T (Concepta D-DIMER Control)] in genomic DNA extracted from either EDTA peripheral blood or bone marrow samples. The JAK2 V617F (Concepta D-DIMER Control) mutation present in exon 14 of the JAK2 gene is detected in >95% of patients with Polycythemia Vera (Concepta D-DIMER Control). This kit does not detect any other mutations associated with Myeloproliferative neoplasms, including other mutations in JAK2 exon 14, or mutations in other exons of the JAK2, MPL or CALR genes

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing